Wesley Bolch

Dr. Wesley E. Bolch is Distinguished Professor of Biomedical Engineering and Medical Physics in the J. Crayton Pruitt Family Department of Biomedical Engineering at the University of Florida (UF). He serves as Director of ALRADS – the Advanced Laboratory for Radiation Dosimetry Studies at UF. In 2011, Dr. Bolch was elected Fellow of both the Health Physics Society (HPS) and the American Association of Physicists in Medicine (AAPM). In 2020, he was inducted as Fellow of the American Institute for Medical and Biological Engineering.  He has been a member of the Society of Nuclear Medicine’s Medical Internal Radiation Dose (MIRD) Committee since 1993, a member of the National Council on Radiation Protection and Measurements (NCRP) since 2005, a member of Committee 2 of the International Commission on Radiological Protection (ICRP) from 2005 to 2021, and a member of US delegation of the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) since 2015. Within the latter, he served as Lead Coordinating Writer for the Expert Group on Second Primary Cancers following Radiotherapy. He has published over 300 peer-reviewed journal articles, co-authored/edited 27 books/book chapters, and served as author on two AAPM Reports, three MIRD Monographs, three NCRP Reports, twelve ICRP Publications, and one ICRU Report. Dr. Bolch manages a broad research program including (1) projects to construct high-resolution models of the skeleton to support dose-response studies in radionuclide therapy and radiation epidemiology, (2) projects to develop scalable NURBS-based and voxel-based computational phantoms of adult and pediatric patients and associated software for organ dose assessment in nuclear medicine, computed tomography, interventional fluoroscopy, and radiotherapy, (3) projects to develop stereotactic kilovoltage x-ray treatments for age-related macular degeneration and glaucoma, (4) projects in stochastic modeling of worker inhalation and gamma-ray exposures following radiological accidents and potential terrorist events, and (5) projects to reassess the organ dosimetry of the Hiroshima and Nagasaki bomb survivors using modern anatomical voxel phantoms. Over the past five years, his core research activities have been funded by the National Cancer Institute, National Institute for Biomedical Imaging and Bioengineering, the National Institute for Allergy and Infectious Diseases, the Department of Defense, the Department of Energy, and the Radiation Effects Research Foundation.